CoChat
Sign Up
Cited by 132Hormonal and reproductive studiesSexual function and dysfunction studiesAdrenal Hormones and Disorders

A Dose‐Response Study of Testosterone on Sexual Dysfunction and Features of the Metabolic Syndrome Using Testosterone Gel and Parenteral Testosterone Undecanoate

Saad, Farid, Gooren, Louis J., Haider, Ahmad, Yassin, Aksam·2008·Journal of Andrology
DOI 10.2164/jandrol.107.002774
Open this paper in CoChat — free account

Abstract

ABSTRACT: The objective of this study was to observe the dose‐response effects of testosterone (T) treatment on symptoms of sexual dysfunction and the metabolic syndrome. Two cohorts of elderly men with late‐onset hypogonadism were followed over 9 months. Group 1, consisting of 28 men (mean age, 61 years; mean T level, 2.07 ± 0.50 ng/mL), received long‐acting T undecanoate (TU; 1000 mg); group 2, composed of 27 men (mean age, 60 years; mean T level, 2.24 ± 0.41 ng/mL), received T gel (50 mg/day) for 9 months. In patients treated with T gel, plasma T levels rose from 2.24 ± 0.41 to 2.95 ± 0.52 (statistically significant) at 3 months, 3.49 ± 0.89 (statistically significant) at 6 months, and 3.80 ± 0.73 ng/mL at 9 months (T level at 6 months was compared with T level at 3 months). With TU, plasma T levels rose from 2.08 ± 0.56 to 4.81 ± 0.83 (statistically significant) at 3 months, 5.29 ± 0.91 at 6 months, and 5.40 ± 0.77 ng/mL at 9 months. With TU, the plasma T levels were statistically significantly higher than with T gel With TU, there was a greater improvement in sexual symptoms and in symptoms of the metabolic syndrome. With both treatments, changes in waist circumference correlated with changes in total, low‐density, and high‐density lipoprotein cholesterol. Parameters of safety were not different between the 2 treatments. T administration had a beneficial effect on sexual dysfunction and symptoms of the metabolic syndrome in elderly men. The higher plasma levels of T generated with TU than with T gel were clearly more effective, indicating that there is a T dose‐effect relationship.

Integrity signals

Registry

Crossref · 10.2164/jandrol.107.002774

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the authors' own studies, signs and symptoms of the metabolic syndrome improved substantially following administration of long-acting testosterone undecanoate, and improvements in glycemic control and lipids parallel improvements in body composition.

    “In our own studies, signs and symptoms of the metabolic syndrome improved substantially following administration of long-acting testosterone undecanoate (32, 35, 92) and improvements in glycemic control and lipids parallel improvements in body composition.”

    From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [92]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Saad, F., Gooren, L. J., Haider, A., & Yassin, A.
Affiliations
  • Gulf Medical University (AE)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Corresponding author
Saad, Farid
ORCID
Venue
Journal of Andrology
Publisher
Wiley
Published
2008-01-02
Volume
29
Issue
1
Pages
102-105
ISSN
  • 0196-3635 (ISSN-L)
  • 1939-4640
DOI
10.2164/jandrol.107.002774
OpenAlex
W2081710331
Cited by
132
References
22
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 17 · 2013: 7 · 2012: 8
FWCI
11.21
Type
journal article
Language
en
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor, 1827 d)
Locations
  • Journal of Andrology (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
testosterone, testosterone undecanoate, testosterone gel, andropause, sexual dysfunction, metabolic syndrome, dose-response relationship, older men, plasma testosterone, waist circumference, lipoproteins, testosterone replacement therapy
MeSH terms
Administration, Topical, Body Weight, Dose-Response Relationship, Drug, Gels, Humans, Injections, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Sexual Dysfunction, Physiological, Testosterone, Triglycerides, Cohort Studies, Metabolic Syndrome, Testosterone Congeners

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review